Eplerenone reduces primary endpoint in acute myocardial infarction patients

A drug known to reduce mortality rate in patients with heart failure has now been found significantly effective when administered early in patients following an acute (ST elevated) myocardial infarction. This effect,say the investigators, was consistent across all study sub-groups, but was "particularly obvious in patients undergoing reperfusion within six hours of symptom onset". Read more Topics: Heart Failure (HF)
Source: ESC News and Press - Category: Cardiology Source Type: news